AAAAAA

   
Results: 1-11 |
Results: 11
POTENT INTERACTION OF HISTAMINE AND POLYAMINES AT MICROSOMAL CYTOCHROME-P450, NUCLEI, AND CHROMATIN FROM RAT HEPATOCYTES
Authors: BRANDES LJ QUEEN GM LABELLA FS
Citation: Lj. Brandes et al., POTENT INTERACTION OF HISTAMINE AND POLYAMINES AT MICROSOMAL CYTOCHROME-P450, NUCLEI, AND CHROMATIN FROM RAT HEPATOCYTES, Journal of cellular biochemistry, 69(3), 1998, pp. 233-243
THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE.HCL, MAY POTENTIATE DOXORUBICIN IN THE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PILOT-STUDY
Authors: BRANDES LJ BRACKEN SP
Citation: Lj. Brandes et Sp. Bracken, THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE.HCL, MAY POTENTIATE DOXORUBICIN IN THE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PILOT-STUDY, Breast cancer research and treatment, 49(1), 1998, pp. 61-68
SALUTARY CLINICAL-RESPONSE OF PROSTATE-CANCER TO ANTIANDROGEN WITHDRAWAL - ASSESSMENT OF FLUTAMIDE IN AN IN-VITRO PARADIGM PREDICTIVE OF TUMOR-GROWTH ENHANCEMENT
Authors: BRANDES LJ QUEEN GM LABELLA FS
Citation: Lj. Brandes et al., SALUTARY CLINICAL-RESPONSE OF PROSTATE-CANCER TO ANTIANDROGEN WITHDRAWAL - ASSESSMENT OF FLUTAMIDE IN AN IN-VITRO PARADIGM PREDICTIVE OF TUMOR-GROWTH ENHANCEMENT, Clinical cancer research, 3(8), 1997, pp. 1357-1361
ENHANCEMENT OF TUMOR-GROWTH BY DRUGS WITH SOME COMMON MOLECULAR ACTIONS
Authors: LABELLA FS BRANDES LJ
Citation: Fs. Labella et Lj. Brandes, ENHANCEMENT OF TUMOR-GROWTH BY DRUGS WITH SOME COMMON MOLECULAR ACTIONS, Molecular carcinogenesis, 16(2), 1996, pp. 68-76
BRANDES AND CHEANG REPLY TO COMMENTS ON FLUOXETINE IN CARCINOGENICITY
Authors: BRANDES LJ CHEANG M
Citation: Lj. Brandes et M. Cheang, BRANDES AND CHEANG REPLY TO COMMENTS ON FLUOXETINE IN CARCINOGENICITY, Journal of clinical psychopharmacology, 16(4), 1996, pp. 337-339
CAN THE CLINICAL COURSE OF CANCER BE INFLUENCED BY NON-ANTINEOPLASTICDRUGS
Authors: BRANDES LJ FRIESEN LA
Citation: Lj. Brandes et La. Friesen, CAN THE CLINICAL COURSE OF CANCER BE INFLUENCED BY NON-ANTINEOPLASTICDRUGS, CMAJ. Canadian Medical Association journal, 153(5), 1995, pp. 561-566
N,N-DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE IN COMBINATION WITHCYCLOPHOSPHAMIDE - AN ACTIVE, LOW-TOXICITY REGIMEN FOR METASTATIC HORMONALLY UNRESPONSIVE PROSTATE-CANCER
Authors: BRANDES LJ BRACKEN SP RAMSEY EW
Citation: Lj. Brandes et al., N,N-DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE IN COMBINATION WITHCYCLOPHOSPHAMIDE - AN ACTIVE, LOW-TOXICITY REGIMEN FOR METASTATIC HORMONALLY UNRESPONSIVE PROSTATE-CANCER, Journal of clinical oncology, 13(6), 1995, pp. 1398-1403
RESPONSE TO ANTIDEPRESSANTS AND CANCER - CAUSE FOR CONCERN
Authors: BRANDES LJ CHEANG M
Citation: Lj. Brandes et M. Cheang, RESPONSE TO ANTIDEPRESSANTS AND CANCER - CAUSE FOR CONCERN, Journal of clinical psychopharmacology, 15(1), 1995, pp. 84-85
ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES - REPLY
Authors: BRANDES LJ LABELLA FS WARRINGTON RC
Citation: Lj. Brandes et al., ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES - REPLY, Journal of the National Cancer Institute, 86(17), 1994, pp. 1355-1356
ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES
Authors: BRANDES LJ WARRINGTON RC ARRON RJ BOGDANOVIC RP FANG W QUEEN GM STEIN DA TONG JG ZABORNIAK CLF LABELLA FS
Citation: Lj. Brandes et al., ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES, Journal of the National Cancer Institute, 86(10), 1994, pp. 770-775
RESULTS OF A CLINICAL-TRIAL IN HUMANS WITH REFRACTORY CANCER OF THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE-HCL, IN COMBINATION WITH VARIOUS SINGLE ANTINEOPLASTIC AGENTS
Authors: BRANDES LJ SIMONS KJ BRACKEN SP WARRINGTON RC
Citation: Lj. Brandes et al., RESULTS OF A CLINICAL-TRIAL IN HUMANS WITH REFRACTORY CANCER OF THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE-HCL, IN COMBINATION WITH VARIOUS SINGLE ANTINEOPLASTIC AGENTS, Journal of clinical oncology, 12(6), 1994, pp. 1281-1290
Risultati: 1-11 |